<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="793" width="595">
	<fontspec id="0" size="10" family="ANEBOG+AdvTT86d47313" color="#231f20"/>
	<fontspec id="1" size="10" family="ANEDAC+AdvTT86d47313+03" color="#231f20"/>
	<fontspec id="2" size="8" family="ANEBMB+AdvTTaf7f9f4f.B" color="#231f20"/>
	<fontspec id="3" size="8" family="ANEBNE+AdvTT99c4c969" color="#231f20"/>
	<fontspec id="4" size="8" family="ANEBMD+AdvTTb5929f4c" color="#231f20"/>
	<fontspec id="5" size="8" family="ANEBMC+AdvTTe45e47d2" color="#231f20"/>
	<fontspec id="6" size="8" family="ANECNC+AdvTT7329fd89.I" color="#231f20"/>
<text top="438" left="57" width="234" height="9" font="0">factors [<a href="">8]. </a>This was clearly demonstrated by our gene</text>
<text top="450" left="57" width="234" height="9" font="0">expression kinetics study which showed the inflamma-</text>
<text top="462" left="57" width="234" height="9" font="0">tory tissue as the site of the highest expression of BMP</text>
<text top="474" left="57" width="40" height="9" font="0">and TGF-</text>
<text top="471" left="97" width="5" height="13" font="1">β</text>
<text top="474" left="102" width="7" height="9" font="0">1.</text>
<text top="486" left="65" width="226" height="9" font="0">A significant focus of research on tissue engineering</text>
<text top="498" left="57" width="234" height="9" font="0">has been the developing of ideal carriers for bone growth</text>
<text top="510" left="57" width="234" height="9" font="0">factors [<a href="">20]. </a>The carrier should act as three-dimensional</text>
<text top="522" left="57" width="234" height="9" font="0">space scaffolding across which de novo bone formation</text>
<text top="534" left="57" width="234" height="9" font="0">can occur; and also should maintain an effective concen-</text>
<text top="546" left="57" width="234" height="9" font="0">tration of growth factors and containing them in order</text>
<text top="558" left="57" width="234" height="9" font="0">to avoid extraneous bone formation. Collagen is considered</text>
<text top="570" left="57" width="234" height="9" font="0">a good carrier, because it is a good source of adhesion-</text>
<text top="582" left="57" width="234" height="9" font="0">signaling molecules and is also a support for blood vessels</text>
<text top="594" left="57" width="234" height="9" font="0">and parenchymal cells. We used a type I collagen sponge</text>
<text top="606" left="57" width="234" height="9" font="0">as carrier, because it is also osteoinductive and favored vas-</text>
<text top="618" left="57" width="234" height="9" font="0">cular growth due to its physical characteristics. There is</text>
<text top="630" left="57" width="234" height="9" font="0">also a good amount of fibrous tissue in the omentum,</text>
<text top="642" left="57" width="234" height="9" font="0">which contributed to the confinement of the implant and</text>
<text top="654" left="57" width="234" height="9" font="0">growth factors, avoiding the bone production outside the</text>
<text top="666" left="57" width="234" height="9" font="0">implant and facilitates its surgical resection avoiding the</text>
<text top="678" left="57" width="98" height="9" font="0">formation of adherences.</text>
<text top="690" left="65" width="226" height="9" font="0">Other essential elements in bone formation are specific</text>
<text top="702" left="57" width="234" height="9" font="0">growth factors, such as BMP, FGF, PDGF, IGFs <a href="">[21,22</a>].</text>
<text top="714" left="57" width="234" height="9" font="0">BMP is the largest sub group of growth factors that belong</text>
<text top="726" left="57" width="50" height="9" font="0">to the TGF-</text>
<text top="723" left="106" width="5" height="13" font="1">β</text>
<text top="726" left="115" width="175" height="9" font="0">superfamily; they are pleiotropic regulators</text>
<text top="438" left="305" width="234" height="9" font="0">that mediate various sequential cellular responses such as:</text>
<text top="450" left="305" width="234" height="9" font="0">chemotaxis and proliferation of progenitor cells, differen-</text>
<text top="462" left="305" width="234" height="9" font="0">tiation into osteoblast, vascular invasion, bone formation,</text>
<text top="474" left="305" width="234" height="9" font="0">remodeling and bone marrow differentiation [<a href="">6,21</a>]. For</text>
<text top="486" left="305" width="234" height="9" font="0">bone induction, the most commonly utilized BMPs are</text>
<text top="498" left="305" width="234" height="9" font="0">BMP2 and 7. BMP2 acts upstream inducing global cellular</text>
<text top="510" left="305" width="234" height="9" font="0">mobilization (day 1 to 3), whereas BMP7 acts on bone dif-</text>
<text top="522" left="305" width="234" height="9" font="0">ferentiation (day 2 to 5) [<a href="">2]</a>. These kinetics patterns were</text>
<text top="534" left="305" width="234" height="9" font="0">also observed in our model, during the first week of im-</text>
<text top="546" left="305" width="234" height="9" font="0">plantation BMP2 was highly expressed, while BMP7 raised</text>
<text top="558" left="305" width="234" height="9" font="0">its maximal expression during the second week. We pro-</text>
<text top="570" left="305" width="234" height="9" font="0">duced both factors in tobacco leaves as recombinant pro-</text>
<text top="582" left="305" width="234" height="9" font="0">teins and added into the implants. After one month, 60%</text>
<text top="594" left="305" width="234" height="9" font="0">and 45% of the implant was constituted by trabecular</text>
<text top="606" left="305" width="234" height="9" font="0">bone when added BMP-2 or BMP-7 respectively. The in-</text>
<text top="618" left="305" width="234" height="9" font="0">duction of cell proliferation by both BMPs was demon-</text>
<text top="630" left="305" width="234" height="9" font="0">strated by the immunohistochemistry detection of the cell</text>
<text top="642" left="305" width="234" height="9" font="0">proliferation marker PCNA, which showed numerous</text>
<text top="654" left="305" width="234" height="9" font="0">positive cells in the mesenchymal tissue around bone tra-</text>
<text top="666" left="305" width="234" height="9" font="0">beculae. Thus both recombinant proteins are efficient in-</text>
<text top="678" left="305" width="234" height="9" font="0">ducing a more rapid bone production in this model.</text>
<text top="690" left="305" width="234" height="9" font="0">Indeed, both BMPs are now available in the clinical setting</text>
<text top="702" left="305" width="234" height="9" font="0">[<a href="">2]</a>, and recent evidence has shown that heterodimeric</text>
<text top="714" left="305" width="234" height="9" font="0">BMPs may have a greater effect than homodimers alone</text>
<text top="726" left="305" width="234" height="9" font="0">[<a href="">23</a>]. However in our experimental conditions, we did not</text>
<text top="380" left="63" width="29" height="7" font="2">Figure 3</text>
<text top="380" left="95" width="414" height="7" font="3">Determination of the percentage of bone tissue by automated morphometry after one and four weeks of implantation</text>
<text top="390" left="63" width="127" height="7" font="3">adding the indicated growth factors.</text>
<text top="390" left="192" width="322" height="7" font="4">Results are presented as means and standard deviation of three different dogs in the indicated time</text>
<text top="400" left="63" width="461" height="7" font="4">points. Mix means implants with the three factors in the same concentration. Asterisk represent statistical difference (p &lt; 0.005) among the indicated</text>
<text top="410" left="63" width="212" height="7" font="4">groups. Two independent experiments were run with similar results.</text>
<text top="35" left="57" width="53" height="7" font="5">Jacinto-Tinajero</text>
<text top="35" left="112" width="140" height="8" font="6">et al. Journal of Experimental Orthopaedics</text>
<text top="35" left="254" width="18" height="7" font="5">2014,</text>
<text top="35" left="275" width="4" height="7" font="2">1</text>
<text top="35" left="279" width="10" height="7" font="5">:11</text>
<text top="35" left="500" width="38" height="7" font="5">Page 6 of 8</text>
<text top="45" left="57" width="139" height="7" font="5">http://www.jeo-esska.com/content/1/1/11</text>
</page>
</pdf2xml>
